http://pawarlawgroup.com/cases/edge-therapeutics-inc/ or call Vik Pawar, Esq. toll-free at 888-589-9804 or email vik@pawarlawgroup.com for information on the class action.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. You may also remain an absent class member and do nothing at this point. You may retain counsel of your choice.

According to the lawsuit, defendants during the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) the company's lead product candidate, EG-1962, would likely fail a futility analysis in connection with the NEWTON 2 study; and (2) as a result, Edge Therapeutics' financial statements and defendants' statements about the company's business, operations, and prospects, were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 22, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://pawarlawgroup.com/cases/edge-therapeutics-inc/ to join the class action. You may also contact Vik Pawar of Pawar Law Group toll free at 888-589-9804 or via email at vik@pawarlawgroup.com.

Pawar Law Group represents investors from around the world.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact:

Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1210
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
info@pawarlawgroup.com

SOURCE: Pawar Law Group

ReleaseID: 503109

"/> EDGE NOTICE: Important June 22, 2018 Lead Plaintiff Deadline in Class Action Says Pawar Law – EDGE « MarketersMedia – Press Release Distribution Services – News Release Distribution Services
Great News! MarketersMedia is officially entering into a long-term partnership with Vertical News Network.
Learn More
How It Works? Plans & Pricing Our Distributions Newsroom Info Hub Sign Up Sign In Send Press Release Contact Sales
Contact Sales Sign Up Your Account Send Press Release
MarketersMEDIA / Newsroom / EDGE NOTICE: Important June 22, 2018 Lead Plaintiff Deadline in Class Action Says Pawar Law – EDGE

EDGE NOTICE: Important June 22, 2018 Lead Plaintiff Deadline in Class Action Says Pawar Law – EDGE

Share This Press Release

NEW YORK, NY / ACCESSWIRE / June 19, 2018 / Pawar Law Group reminds shareholders who purchased shares of Edge Therapeutics, Inc. (NASDAQ: EDGE) from December 29, 2017 through March 27, 2018, both dates inclusive (the "Class Period") of the important June 22, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Edge Therapeutics investors under the federal securities laws. To join the Edge Therapeutics class action, go to http://pawarlawgroup.com/cases/edge-therapeutics-inc/ or call Vik Pawar, Esq. toll-free at 888-589-9804 or email vik@pawarlawgroup.com for information on the class action.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. You may also remain an absent class member and do nothing at this point. You may retain counsel of your choice.

According to the lawsuit, defendants during the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) the company's lead product candidate, EG-1962, would likely fail a futility analysis in connection with the NEWTON 2 study; and (2) as a result, Edge Therapeutics' financial statements and defendants' statements about the company's business, operations, and prospects, were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 22, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://pawarlawgroup.com/cases/edge-therapeutics-inc/ to join the class action. You may also contact Vik Pawar of Pawar Law Group toll free at 888-589-9804 or via email at vik@pawarlawgroup.com.

Pawar Law Group represents investors from around the world.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact:

Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1210
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
info@pawarlawgroup.com

SOURCE: Pawar Law Group

ReleaseID: 503109

NEW YORK, NY / ACCESSWIRE / June 19, 2018 / Pawar Law Group reminds shareholders who purchased shares of Edge Therapeutics, Inc. (NASDAQ: EDGE) from December 29, 2017 through March 27, 2018, both dates inclusive (the "Class Period") of the important June 22, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Edge Therapeutics investors under the federal securities laws. To join the Edge Therapeutics class action, go to http://pawarlawgroup.com/cases/edge-therapeutics-inc/ or call Vik Pawar, Esq. toll-free at 888-589-9804 or email vik@pawarlawgroup.com for information on the class action.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. You may also remain an absent class member and do nothing at this point. You may retain counsel of your choice.

According to the lawsuit, defendants during the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) the company's lead product candidate, EG-1962, would likely fail a futility analysis in connection with the NEWTON 2 study; and (2) as a result, Edge Therapeutics' financial statements and defendants' statements about the company's business, operations, and prospects, were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 22, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://pawarlawgroup.com/cases/edge-therapeutics-inc/ to join the class action. You may also contact Vik Pawar of Pawar Law Group toll free at 888-589-9804 or via email at vik@pawarlawgroup.com.

Pawar Law Group represents investors from around the world.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact:

Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1210
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
info@pawarlawgroup.com

SOURCE: Pawar Law Group

ReleaseID: 503109

Source URL: https://marketersmedia.com/edge-notice-important-june-22-2018-lead-plaintiff-deadline-in-class-action-says-pawar-law-edge/362468

Source: AccessWire

Release ID: 362468

Our Client

Subscribe and Recieve exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2018 MarketersMedia – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).